Global in vitro diagnostics market share by top medtech companies 2017 and 2024

This statistic describes the top 10 medical technology companies for in vitro diagnostics in 2017 and 2024, based on market share. In 2017, Sysmex accounted for 4.4 percent of the global market for in vitro diagnostics. By 2024, this share is expected to increase slightly to 4.5 percent. In vitro diagnostics allows for medical professionals to detect diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes at within a patient's home.

Global top 10 companies based on in vitro diagnostics market share in 2017 and 2024

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

September 2018



Survey time period

as of September 2018

Supplementary notes

Market share based on revenues. Excludes glucose test systems which are included in diabetic care classification.
* Projected.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.